Home  Clinical trials Products in Development AZD5672
|
|
A number of clinical trials with AZD5672 Ongoing studies are currently in progress.
More studies will be added in due course. Additional AZD5672 Ongoing study information is available on ClinicalTrials.gov. | Study Number | Study Phase | Start Date | Recruitment Status | | D1710C00009 | Phase II | 1 Jul 2008 | Recruiting | | A Randomised, Double Blind, Placebo Controlled, Phase IIb Dose Ranging Study (with Open-label Etanercept Treatment Group) to Investigate Efficacy, Safety and Pharmacokinetics of AZD5672 Administered for 12 Weeks to Rheumatoid Arthrititis Patients Receiving Methotrexate. | | D1710C00010 | Phase I | 13 Jun 2008 | Completed | | An Open-Label, Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics following a Single Oral Dose of [14C]AZD5672 in Healthy Male Volunteers | | D1710C00018 | Phase I | 27 Aug 2008 | Recruiting | | A Phase I Study to Assess Absolute Bioavailability of AZD5672 at Steady-state in Healthy Volunteers | | D1710C00020 | Phase I | 3 Jul 2008 | Recruiting | | An Open-label, Single-Centre, Parallel Group, Phase I Study To Compare the Pharmacokinetics of AZD5672 Single Dose in Patients with Renal Impairment and Healthy Volunteers | | D1710C00021 | Phase I | 3 Jul 2008 | Recruiting | | An Open-label Study to Assess the Effect of AZD5672 at Steady State on the Pharmacokinetics of Digoxin Following Single Dose Administration in Healthy Volunteers | | D1710C00025 | Phase I | 14 Jul 2008 | Completed | | A Phase I, Single Centre, Open-label Study to Assess the Pharmacokinetics of Both AZD5672 (Steady-state) and Atorvastatin (Single Dose) When Co administered in Healthy Volunteers |
|
|
|
|